NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG 2 hepatoma cell line

European Journal of Pharmacology

Volumn 672, Issue 1-3, 2011, Pages 113-120

  Zuo, Qing Ping ^a,b   Liu, Shi Kun ^a   Li, Zuo Jun ^a   Li, Bing ^a   Zhou, Yu Lu ^a   Guo, Ren ^a   Huang, Li Hua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b First Hospital of Changsha City   (China)

Author keywords

Dexamethasone; Hepatocellular carcinoma; hTERT; LPS; MG 132; NF kappaB

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DEXAMETHASONE; LIPOPOLYSACCHARIDE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE EXPRESSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; LEUPEPTINS; LIPOPOLYSACCHARIDES; MOLECULAR TARGETED THERAPY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TELOMERASE; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 81255157509     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.187     Document Type: Article

References (45)

1. M. Akiyama, T. Hideshima, T. Hayashi, Y.T. Tai, C.S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N.C. Munshi, and K.C. Anderson Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein Cancer Res. 63 2003 18 21 (Pubitemid 36070412)
2. D.M. Baird Variation at the TERT locus and predisposition for cancer Expert Rev. Mol. Med. 12 2010 (Article No.: e16)
3. V. Baud, and M. Karin Opinion: is NF-kappa B a good target for cancer therapy? Hopes and pitfalls Nat. Rev. Drug Discov. 8 2009 33 40
4. A. Beliveau, E. Bassett, A.T. Lo, J. Garbe, M.A. Rubio, M.J. Bissell, J. Campisi, and P. Yaswen P53-dependent integration of telomere and growth factor deprivation signals Proc. Natl. Acad. Sci. 104 2007 4431 4436 (Pubitemid 47186243)
5. L. Boldrini, S. Pistolesi, S. Gisfredi, S. Ursino, G. Ali, N. Pieracci, F. Basolo, G. Parenti, and G. Fontanini Telomerase activity and hTERT mRNA expression in glial tumors Int. J. Oncol. 28 2006 1555 1560
6. C.E. Bryant, D.R. Spring, M. Gangloff, and N.J. Gay The molecular basis of the host response to lipopolysaccharide Nat. Rev. Microbiol. 8 2010 8 14
7. S. Cao, X. Zhang, J.P. Edwards, and D.M. Mosser NF-κB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages J. Biol. Chem. 281 2006 26041 26050 (Pubitemid 44401810)
8. X. Cao, H. Xiao, Y. Zhang, L. Zou, Y. Chu, and X. Chu 1, 5-Dicaffeoylquinic acid-mediated glutathione synthesis through activation of Nrf2 protects against OGD/reperfusion-induced oxidative stress in astrocytes Brain Res. 1347 2010 142 148
9. S. Courtois-Cox, S.M. Genther-Williams, E.E. Reczek, B.W. Johnson, L.T. McGillicuddy, C.M. Johannessen, P.E. Hollstein, M. MacCollin, and K. Cichowski A negative feedback signaling network underlies oncogene-induced senescence Cancer Cell 10 2006 459 472 (Pubitemid 44872980)
10. Z.N. Demidenko, and M.V. Blagosklonny Growth stimulation leads to cellular senescence when the cell cycle is blocked Cell Cycle 7 2008 3355 3361
11. X. Dolcet, D. Llobet, J. Pallares, and G.X. Matias NF-kB in development and progression of human cancer Virchows Arch. 446 2005 475 482 (Pubitemid 40884279)
12. S. Duangmano, S. Dakeng, W. Jiratchariyakul, A. Suksamrarn, D.R. Smith, and P. Patmasiriwat Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle Int. J. Mol. Sci. 11 2011 5323 5338
13. A.M. Elsharkawy, and D.A. Mann Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis Hepatology 46 2007 590 597 (Pubitemid 47344795)
14. E.L. Greer, and A. Brunet Signaling networks in aging J. Cell Sci. 121 2008 407 412 (Pubitemid 351405048)
15. X. Guo, and A.A. Mills P63, cellular senescence and tumor development Cell Cycle 6 2007 305 311
16. L. Hernandez, S.C. Hsu, B. Davidson, M.J. Birrer, E.C. Kohn, and C.M. Annunziata Activation of NF-KB signaling by inhibitor of NF-KB kinase beta increases aggressiveness of ovarian cancer Cancer Res. 70 2010 4005 4014
17. Y. Ito, H. Yoshida, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, and A. Miyauchi Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT) Anticancer Res. 25 2005 509 514 (Pubitemid 40470058)
18. M.O. Kim, D.O. Moon, S.H. Kang, M.S. Heo, Y.H. Choi, J.H. Jung, J.D. Lee, and G.Y. Kim Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation FEBS Lett. 582 2008 3263 3269
19. S. Kyo, M. Takakura, T. Fujiwara, and M. Inoue Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers Cancer Sci. 99 2008 1528 1538
20. D.H. Lee, and A.L. Goldberg Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Sac-charomyces cerevisiae J. Biol. Chem. 271 1996 27280 27284 (Pubitemid 26367280)
21. S.D. Lima, Horikawa l., E. Michishita, A. Datta, J.C. Sigler-Nicot, M. Brown, M. Kazanji, J.C. Barrett, and C. Nicot Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I-transformed cells Blood 104 2004 2523 2531 (Pubitemid 39331856)
22. L.F. Liu, K. Ishihara, T. Ichimura, N. Fujita, S. Hino, S. Tomita, S. Watanabe, N. Saitoh, T. Ito, and M. Nakao MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity J. Biol. Chem. 284 2009 5165 5174
23. J.L. Luo, H. Kamata, and M. Karin The anti-death machinery in IKK/NF-kappaB signaling J. Clin. Immunol. 25 2005 541 550
24. S.I. Miller, R.K. Ernst, and M.W. Bader LPS, TLR4 and infectious disease diversity Nat. Rev. Microbiol. 3 2005 36 46 (Pubitemid 40028467)
25. D.O. Moon, M.O. Kim, J.D. Lee, Y.H. Choi, and G.Y. Kim Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells Cancer Lett. 286 2009 172 179
26. J.L. Osterhage, and K.L. Friedman Chromosome end maintenance by telomerase J. Biol. Chem. 284 2009 16061 16065
27. L. Qiao, H. Zhang, J. Yu, R. Francisco, P. Dent, M.P.A. Ebert, C. Rocken, and G. Farrell Constitutive activation of NF-kappa B in human hepatocellular carcinoma: evidence of a cytoprotective role Hum. Gene Ther. 17 2006 280 290
28. T. Rhen, and J.A. Cidlowski Antiinflammatory action of glucocorticoids-new mechanisms for old drugs N. Engl. J. Med. 353 2005 1711 1723
29. M. Sherman Hepatocellular carcinoma: epidemiology, risk factors, and screening Semin. Liver Dis. 25 2005 143 154 (Pubitemid 40781067)
30. N. Shintaro, H. Yasuaki, and M. Muneki Dexamethasone inhibits interleukin-1β-induced corneal neovascularization Am. J. Pathol. 171 2007 1058 1065
31. D. Shore, and A. Bianchi Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase EMBO J. 28 2009 2309 2322
32. E. Sykorova, and J. Fajkus Structure-function relationships in telomerase genes Biol. Cell 101 2009 375 392
33. D.I. Tai, S.L. Tsai, and Y.H. Chang Constitutive activation of nuclear factor κB in hepatocellular carcinoma Cancer 89 2000 2274 2281
34. H. Tsukamoto, K. Fukudome, S. Takao, N. Tsuneyoshi, and M. Kimoto Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells Int. Immunol. 22 2010 271 280
35. T. Urbanik, B.C. Kohler, R.J. Boger, M.A. Worns, S. Heeger, G. Otto, N. Hovelmeyer, P.R. Galle, M. Schuchmann, A. Waisman, and H. Schulze-Bergkamen Down-regulation of CYLD as a trigger for NF-kappa B activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells Int. J. Oncol. 38 2011 121 131
36. W. Van Molle, and C. Libert How glucocorticoids control their own strength and the balance between pro- and anti-inflammatory mediators Eur. J. Immunol. 35 2005 3396 3399 (Pubitemid 43025519)
37. J.C. Wang, and M.R. Bennett Nuclear factor-κB-mediated regulation of telomerase: the myc link Arterioscler. Thromb. Vasc. Biol. 30 2010 2327 2328
38. C.Y. Wang, M.W. Mayo, and A.S. Baldwin TNF-a and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 274 1996 784 787 (Pubitemid 26398259)
39. W. Wang, H.S. Luo, and B.P. Yu Expression of NF-κB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions World J. Gastroenterol. 10 2004 177 181 (Pubitemid 38195256)
40. S.L. Wang, Z.J. Liu, L.S. Wang, and X.R. Zhang NF-kappa B signaling pathway, inflammation and colorectal cancer Cell. Mol. Immunol. 6 2010 327 334
41. A. Wullaert, G.V. Loo, K. Heyninck, and R. Beyaert Hepatic tumor necrosis factor signaling and nuclear factor-κB: effects on liver homeostasis and beyond Endocr. Rev. 28 4 2007 365 386 (Pubitemid 46984825)
42. Z. Xua, S. Linb, W. Wua, H. Tana, Z. Wangc, C. Chengd, L. Lua, and X. Zhang Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms Toxicology 247 2008 133 138
43. X. Ye, B. Zerlanko, A. Kennedy, G. Banumathy, R. Zhang, and P.D. Adams Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells Mol. Cell 27 2007 183 196 (Pubitemid 47058300)
44. L. Yin, A.K. Hubbard, and C. Giardina NF-κB regulates transcription of the mouse telomerase catalytic subunit J. Biol. Chem. 275 2000 36671 36675 (Pubitemid 32002070)
45. M.I. Zvereva, D.M. Shcherbakova, and O.A. Dontsova Telomerase: structure, functions, and activity regulation Biochem-MOSCOW. 75 2010 1563 1583